De Backer Marianne — SEC Form 4 filings
SEC reporting owner CIK 1797819. 9 Form 4 filings on record with FilingPulse; latest filed 2026-04-30.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-26 to 2026-04-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 275,189 shares, $2,263,975 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 72,995 shares @ $9.46 ($690,365) in Vir Biotechnology, Inc., filed 2024-04-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | President and CEO, Director | 9 | — | 6 legs · 275,189 sh · $2,263,975 | 10 |
Form 4 filings — De Backer Marianne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-30 | 4 | Vir Biotechnology, Inc. (VIR) | Other (J): 233,532 @ $0 · Other (J): 233,532 @ $0 | EDGAR |
| 2026-04-07 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 72,559 @ $9.16 | EDGAR |
| 2026-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 14,762 @ $9.53 | EDGAR |
| 2026-02-24 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 285,000 @ $0 · Sale (S): 19,039 @ $7.45 · Grant/award (A): 570,000 (derivative) @ $0 | EDGAR |
| 2025-04-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 79,712 @ $5.95 | EDGAR |
| 2025-02-25 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 240,000 @ $0 · Sale (S): 16,122 @ $9.45 · Grant/award (A): 480,000 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Vir Biotechnology, Inc. (VIR) | Other (J): 53,118 @ $0 · Other (J): 53,118 @ $0 | EDGAR |
| 2024-04-04 | 4 | Vir Biotechnology, Inc. (VIR) | Sale (S): 72,995 @ $9.46 | EDGAR |
| 2024-02-26 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 175,000 @ $0 · Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797819 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →